BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33556412)

  • 1. Risk of macrophage activation syndrome in patients with adult-onset Still's disease with skin involvement: A retrospective cohort study.
    Ding Y; Tang S; Li S; Yang C; Liu T; Ying S; Zhu D; Sun C; Chen W; Shi Y; Fang H; Qiao J
    J Am Acad Dermatol; 2021 Dec; 85(6):1503-1509. PubMed ID: 33556412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
    Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
    Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
    Gao Q; Yuan Y; Wang Y; Jiang J; Ye Z; Liu T; Jiang Z; Zhao L
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):59-66. PubMed ID: 34251315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
    Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evanescent and persistent pruritic eruptions of adult-onset still disease: a clinical and pathologic study of 36 patients.
    Lee JY; Hsu CK; Liu MF; Chao SC
    Semin Arthritis Rheum; 2012 Dec; 42(3):317-26. PubMed ID: 22717204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological study of adult-onset Still's disease using a Japanese administrative database.
    Sakata N; Shimizu S; Hirano F; Fushimi K
    Rheumatol Int; 2016 Oct; 36(10):1399-405. PubMed ID: 27502500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
    Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
    J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.
    Ruscitti P; Di Cola I; Berardicurti O; Conforti A; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Giacomelli R; Cipriani P
    Clin Rheumatol; 2022 Mar; 41(3):641-647. PubMed ID: 34636022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
    Lenert A; Yao Q
    Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series.
    Bindoli S; Galozzi P; Doria A; Sfriso P
    Joint Bone Spine; 2023 Mar; 90(2):105524. PubMed ID: 36623798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
    Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
    Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heliotrope-like manifestation of adult-onset Still disease with macrophage activation syndrome: A case-based review.
    Ikeda T; Yokoyama K; Kawakami T
    J Dermatol; 2022 Jul; 49(7):736-740. PubMed ID: 35438204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
    Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
    Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage Activation Syndrome Associated With Adult Onset Still's Disease.
    Gulzar M; Sabir A; Hamdani MA; Saadia A
    J Ayub Med Coll Abbottabad; 2018; 30(2):289-292. PubMed ID: 29938438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
    Yao H; Wang Y; Wang Z; Zhao J; Deng X; Zhang Z; Zhao Y; Zhang Y; Shu Q; Jia Y; Li ZG
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):129-134. PubMed ID: 34596030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of MS-Score and HScore in timeliness of diagnosis of macrophage activation syndrome associated with adult-onset Still's disease].
    Peng Z; Gao XM; Zhou S; Wu CY; Zhao JL; Xu D; Li MT; Peng JM; Li J; Wang Q; Tian XF; Zeng X
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2210-2214. PubMed ID: 35872586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.